Get the free PARENTERAL THERAPY FOR SEVERE MALARIA - FORM B - phac-aspc gc

This form is to be completed by the attending physician for patients receiving parenteral therapy for severe malaria.

How to fill out parenteral therapy for severe

How to fill out PARENTERAL THERAPY FOR SEVERE MALARIA - FORM B

1. Begin by reading the instructions on the PARENTERAL THERAPY FOR SEVERE MALARIA - FORM B carefully.
2. Fill in the patient's personal information such as name, age, and sex at the top of the form.
3. Record the date and time of form completion.
4. Indicate the diagnosis by selecting the appropriate box for severe malaria.
5. Document the patient's vital signs, including temperature, blood pressure, and pulse rate.
6. Enter the results of relevant laboratory tests, like blood smears or rapid diagnostic tests for malaria.
7. Specify the medication prescribed, dosage, and route of administration.
8. Outline the duration of the treatment and any follow-up care instructions.
9. Include any notes on allergies or previous reactions to antimalarial drugs.
10. Sign and date the form to certify that all information is accurate.

Who needs PARENTERAL THERAPY FOR SEVERE MALARIA - FORM B?

1. Patients diagnosed with severe malaria, particularly those with severe symptoms or complications.
2. Individuals who are unable to take oral antimalarial medications due to vomiting or unconsciousness.
3. Children and pregnant women who are at higher risk and may require immediate intravenous treatment.

People Also Ask about

What is the parenteral treatment for malaria?

Patients with severe malaria, regardless of infecting species, should be treated with intravenous (IV) artesunate.

What is the protocol for severe malaria treatment?

Give parenteral antimalarials for a minimum of 24hrs once started (irrespective of the patient's ability to tolerate oral medication earlier), and, thereafter, complete treatment by giving a complete course of: – an ACT – artesunate + or – quinine + or .

How to give artesunate in severe malaria?

Each dose of IV artesunate is 2.4 mg/kg. A dose of IV artesunate should be given at 0, 12, and 24 hours. Note that the weight-based dosing applies to both adults and children. Previously, weight-based dosing was differentiated between children <20kg and those ≥20kg.

How is the malaria injection given?

Parenteral artesunate: The recommended treatment for severe malaria. Dosing: Artesunate 2.4 mg/kg body weight (bw) administered intravenously (IV) or intramuscularly (IM) at the time of admission (time=0), then at 12h and 24 h, then once a day until the patient is able to take oral medication.

What is the treatment plan for severe malaria?

Give parenteral antimalarials for a minimum of 24hrs once started (irrespective of the patient's ability to tolerate oral medication earlier), and, thereafter, complete treatment by giving a complete course of: – an ACT – artesunate + or – quinine + or .

What is the best injection for severe malaria?

Artesunate injection is used to treat severe malaria. This medicine is also used together with other medicines (eg, 8-aminoquinoline medicine) to treat severe malaria caused by Plasmodium ovale or Plasmodium vivax. Artesunate belongs to a group of medicines known as antimalarials.

How do you administer injectable artesunate for severe malaria?

Dosage and duration One dose on admission (H0) then 12 hours after admission (H12) then 24 hours after admission (H24) then, once daily. Administer parenterally at least 24 hours (3 doses), then, if the patient can tolerate the oral route, change to a complete 3-day course of an artemisinin-based combination.

What is the protocol for the artesunate injection?

Dosage and duration One dose on admission (H0) then 12 hours after admission (H12) then 24 hours after admission (H24) then, once daily. Administer for at least 24 hours (minimum 3 doses), then, if the patient can tolerate the oral route, change to a full 3-day course of an artemisinin-based combination (ACT).

For pdfFiller’s FAQs

What is PARENTERAL THERAPY FOR SEVERE MALARIA - FORM B?

PARENTERAL THERAPY FOR SEVERE MALARIA - FORM B is a standardized document used to report and document the administration of parenteral therapy for patients diagnosed with severe malaria. It serves as a critical tool in ensuring proper treatment protocols are followed.

Who is required to file PARENTERAL THERAPY FOR SEVERE MALARIA - FORM B?

Healthcare providers, including doctors and nurses, who administer parenteral therapy to patients with severe malaria are required to file PARENTERAL THERAPY FOR SEVERE MALARIA - FORM B.

How to fill out PARENTERAL THERAPY FOR SEVERE MALARIA - FORM B?

To fill out PARENTERAL THERAPY FOR SEVERE MALARIA - FORM B, the healthcare provider must include patient details such as name, age, and medical history, as well as treatment specifics like medication used, dosage, administration route, and timestamps of treatment.

What is the purpose of PARENTERAL THERAPY FOR SEVERE MALARIA - FORM B?

The purpose of PARENTERAL THERAPY FOR SEVERE MALARIA - FORM B is to ensure accurate documentation of treatment for severe malaria, facilitate effective communication among healthcare providers, and provide essential data for monitoring and evaluation of treatment outcomes.

What information must be reported on PARENTERAL THERAPY FOR SEVERE MALARIA - FORM B?

Information that must be reported on PARENTERAL THERAPY FOR SEVERE MALARIA - FORM B includes patient identification details, the date and time of therapy initiation, medication details (name, dosage, route of administration), and any adverse reactions or complications encountered during treatment.